Southland Equity Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Southland Equity Partners's AMGN Position: Q2 2026 in Review
Southland Equity Partners increased its Amgen (AMGN) stake by 2% in Q2 2026, buying an estimated $9.59K and bringing the position to 1,418 shares worth $514K. The position accounts for 0.09% of the portfolio, ranked #164.
Southland Equity Partners first reported a position in AMGN in Q1 2021 and has held it in 20 quarters since. The position peaked at $589K in Q4 2025. 1,452 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Southland Equity Partners held 1,418 shares of Amgen worth $514K as of Q2 2026.
- Southland Equity Partners bought 28 Amgen shares in Q2 2026, an estimated $9.59K.
- Amgen made up 0.09% of Southland Equity Partners's portfolio in Q2 2026, its #164 holding.
- Southland Equity Partners first reported a position in Amgen in Q1 2021 and has held it in 20 quarters since.
- Southland Equity Partners's Amgen position peaked at $589K in Q4 2025.
- 1,452 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Southland Equity Partners's 13F filing for Q2 2026, filed 13 Jul 2026.